Tumor necrosis factor inhibitors (TNFi) are a class of biologic therapies indicated for managing multiple autoimmune diseases, including Inflammatory Bowel Disease1,2 (IBD) and Rheumatoid Arthritis (RA).3 This evidence concerns the gene TNF and rheumatoid arthritis.